Overview

Study of Three Doses of Aripiprazole in Patients With Acute Schizophrenia

Status:
Completed
Trial end date:
2004-09-01
Target enrollment:
Participant gender:
Summary
A study to evaluate three doses of aripiprazole versus placebo in patients with an acute episode of schizophrenia
Phase:
Phase 4
Details
Lead Sponsor:
Otsuka Pharmaceutical Development & Commercialization, Inc.
Collaborator:
Otsuka America Pharmaceutical
Treatments:
Aripiprazole